15-100892597-GCAGGGTGGGCAGACAAAATC-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000693.4(ALDH1A3):c.439_458del(p.Trp147GlnfsTer7) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
ALDH1A3
NM_000693.4 frameshift
NM_000693.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.58
Genes affected
ALDH1A3 (HGNC:409): (aldehyde dehydrogenase 1 family member A3) This gene encodes an aldehyde dehydrogenase enzyme that uses retinal as a substrate. Mutations in this gene have been associated with microphthalmia, isolated 8, and expression changes have also been detected in tumor cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-100892597-GCAGGGTGGGCAGACAAAATC-G is Pathogenic according to our data. Variant chr15-100892597-GCAGGGTGGGCAGACAAAATC-G is described in ClinVar as [Pathogenic]. Clinvar id is 1372977.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALDH1A3 | NM_000693.4 | c.439_458del | p.Trp147GlnfsTer7 | frameshift_variant | 4/13 | ENST00000329841.10 | |
ALDH1A3-AS1 | NR_135827.1 | n.3930_3949del | non_coding_transcript_exon_variant | 2/2 | |||
ALDH1A3 | NM_001293815.2 | c.346-3330_346-3311del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALDH1A3 | ENST00000329841.10 | c.439_458del | p.Trp147GlnfsTer7 | frameshift_variant | 4/13 | 1 | NM_000693.4 | P1 | |
ALDH1A3-AS1 | ENST00000656756.1 | n.4038_4057del | non_coding_transcript_exon_variant | 2/2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Isolated microphthalmia 8 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 23, 2021 | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with ALDH1A3-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp147Glnfs*7) in the ALDH1A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALDH1A3 are known to be pathogenic (PMID: 23312594, 23591992, 24777706). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.